Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Garbage self paid pumping promotion from July, no money soon

<< Previous

Bullboard Posts

Next >>

Comment by SamV21on Nov 02, 2021 8:50pm

71 Views

Post# 34080125

RE:Garbage self paid pumping promotion from July, no money soon

Guy says Qixleef 2023 ,did you pumpers listen to the interview ? if you use the Guy Tetra calender thats probably more like 2025.You guys are pumping like we are all going to be millionairs in the next few months., wait for results because if reduvo fails, then Qixleef will also go no where in Canada.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks